tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Enliven Therapeutics’ Promising Phase 1a/1b Study on ELVN-002 in HER2+ Cancers
PremiumCompany AnnouncementsEnliven Therapeutics’ Promising Phase 1a/1b Study on ELVN-002 in HER2+ Cancers
28d ago
Enliven Therapeutics’ Promising CML Treatment: A Study Update
Premium
Company Announcements
Enliven Therapeutics’ Promising CML Treatment: A Study Update
29d ago
Enliven Therapeutics’ Promising CML Study Update: What Investors Need to Know
Premium
Company Announcements
Enliven Therapeutics’ Promising CML Study Update: What Investors Need to Know
1M ago
Enliven Therapeutics Appoints New Directors at Annual Meeting
PremiumCompany AnnouncementsEnliven Therapeutics Appoints New Directors at Annual Meeting
2M ago
Short Report: Short interest in residential solar heats up again
Premium
The Fly
Short Report: Short interest in residential solar heats up again
2M ago
Enliven price target raised to $52 from $40 at Baird
Premium
The Fly
Enliven price target raised to $52 from $40 at Baird
2M ago
Enliven Therapeutics: Promising Phase 1 Data and Strong Financial Position Support Buy Rating
PremiumRatingsEnliven Therapeutics: Promising Phase 1 Data and Strong Financial Position Support Buy Rating
2M ago
Adobe reports Q2 beat, Meta invests in Scale AI: Morning Buzz
Premium
The Fly
Adobe reports Q2 beat, Meta invests in Scale AI: Morning Buzz
2M ago
Enliven Therapeutics Announces Positive Phase 1 Trial Results
Premium
Company Announcements
Enliven Therapeutics Announces Positive Phase 1 Trial Results
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100